in this issue
Regions :: China
Sinopec and Zhejiang Hengyi Invest $567 Million in Caprolactam JV
3:59 AM MST | December 16, 2011 | Deepti Ramesh
Sinopec says its Sinopec Baling (Yunxi, Hunan Province, China) subsidiary has established a joint venture company with Zhejiang Hengyi Group (Xiaoshan, Zhejiang Province, China) to manufacture caprolactam at Xiaoshan. The jv company Zhejiang Baling Hengyi Caprolactam Co. was established on December 6. Sinopec Baling and Zhejiang Hengyi are investing a total of Rmb3.6 billion ($567 million) in the project which will produce 200,000 m.t./year of caprolactam. The plant is expected to become operational in the second quarter of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee